Pharma News

Primo partners with ABX to bring PB01 closer to Taiwan’s prostate cancer market

In response to the growing burden of prostate cancer in Taiwan, Primo Biotechnology has formed a strategic par

21 March, 2025 | Friday | News
Indian pharma firm Cipla signs multi-regional licensing deal for ophthalmic care with Taiwan's Formosa

India-based Cipla has announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals for

18 March, 2025 | Tuesday | News
Japan grants Orphan Drug Designation to Lundbeck's potential treatment for Multiple System Atrophy

The Ministry of Health, Labour, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD

11 March, 2025 | Tuesday | News

BioTech News

CEPI funds Nagasaki University’s ‘Nanoball’ technology to help defeat Disease X

A new ‘nanoball’ vaccine platform developed by experts in Japan will be tested as part of new rese

10 March, 2025 | Monday | News
Taiwan's Formosa Group invests $12.5 M to establish biomedical research centre in Korea

Taiwan-based Formosa Group Executive Committee member and Chairman Sandy Wang, who leads the group's bio and e

05 March, 2025 | Wednesday | News
China & Europe announce joint laboratory for health and ageing research

Infinitus (China) Company has secured approval for its Sino-British Joint Laboratory on Health and Ageing proj

12 February, 2025 | Wednesday | News

MedTech News

ABL Diagnostics partners with Riken Genesis to expand microbiology genotyping in Japan

ABL Diagnostics, a Euronext-listed leader in molecular diagnostics, has announced an exclusive distribution ag

18 March, 2025 | Tuesday | News
Proteomics International launches predictive test for diabetic kidney disease in Australia

Proteomics International Laboratories, a pioneer in precision diagnostics, has announced the launch of

18 March, 2025 | Tuesday | News

BioServices News

Novotech strengthens clinical trial capabilities in South Korea

Novotech, a global leading full-service clinical Contract Research Organization (CRO), and Acrostar, a provide

19 March, 2025 | Wednesday | News
Avance Clinical inks new partnerships to expand into Taiwan

Avance Clinical, a leading full-service global Contract Research Organization (CRO) specialising in high-quali

18 March, 2025 | Tuesday | News

Inside Magazine

 

Mitigating PATENT CLIFF Fallout 

Monoclonal antibodies (mAbs) represent a $279.8 billion market, projected to reach $804 billion by 2033, according to a report from Dimension Market Research. With patents for many of these valuable drugs set to expire in the coming years, the industry faces significant challenges. In this story, we examine 11 blockbuster mAbs whose patents will expire between 2025 and 2030. These expirations, affecting some of pharma's biggest players, will have a major impact on the market and their revenue streams.

 

Click here to access E-magazine

Video Gallery

Events

View All
18 - 22
Mar - 2025

ACMG Annual Clinical Genetics Meeting 2025

ACMG

pfreire@acmg.net https://www.acmgmeeting.net/

LA USA

24 - 26
Mar - 2025

Immuno-Oncology 360° 2025

The conference forum

service@tcfllc.org https://io360summit.com/agenda/

Boston

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls